These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 8006281)

  • 1. Comparison of the effect of heparin and aspirin versus aspirin alone on transient myocardial ischemia and in-hospital prognosis in patients with unstable angina.
    Holdright D; Patel D; Cunningham D; Thomas R; Hubbard W; Hendry G; Sutton G; Fox K
    J Am Coll Cardiol; 1994 Jul; 24(1):39-45. PubMed ID: 8006281
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low molecular weight heparin versus regular heparin or aspirin in the treatment of unstable angina and silent ischemia.
    Gurfinkel EP; Manos EJ; Mejaíl RI; Cerdá MA; Duronto EA; García CN; Daroca AM; Mautner B
    J Am Coll Cardiol; 1995 Aug; 26(2):313-8. PubMed ID: 7608429
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early continuous ST segment monitoring in unstable angina: prognostic value additional to the clinical characteristics and the admission electrocardiogram.
    Patel DJ; Holdright DR; Knight CJ; Mulcahy D; Thakrar B; Wright C; Sparrow J; Wicks M; Hubbard W; Thomas R; Sutton GC; Hendry G; Purcell H; Fox K
    Heart; 1996 Mar; 75(3):222-8. PubMed ID: 8800982
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of low-dose aspirin and coronary vasodilators in acute unstable angina.
    Vejar M; Hackett D; Brunelli C; Spallarossa P; Ianetti M; Galassi AR; Lipkin D; Caponnetto S; Patrono C; Maseri A
    Circulation; 1990 Jan; 81(1 Suppl):I4-11; discussion I22-3. PubMed ID: 2403867
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prospective comparison of unstable angina versus non-Q wave myocardial infarction during antithrombotic therapy. Antithrombotic Therapy in Acute Coronary Syndromes Research Group.
    Cohen M; Xiong J; Parry G; Adams PC; Chamberlain D; Wieczorek I; Fox KA; McBride R; Chesebro JH; Fuster V
    J Am Coll Cardiol; 1993 Nov; 22(5):1338-43. PubMed ID: 7901254
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparison of aspirin plus tirofiban with aspirin plus heparin for unstable angina.
    Platelet Receptor Inhibition in Ischemic Syndrome Management (PRISM) Study Investigators
    N Engl J Med; 1998 May; 338(21):1498-505. PubMed ID: 9599104
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adding heparin to aspirin reduces the incidence of myocardial infarction and death in patients with unstable angina. A meta-analysis.
    Oler A; Whooley MA; Oler J; Grady D
    JAMA; 1996 Sep; 276(10):811-5. PubMed ID: 8769591
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low molecular weight heparin decreases rebound ischemia in unstable angina or non-Q-wave myocardial infarction: the Canadian ESSENCE ST segment monitoring substudy.
    Goodman SG; Barr A; Sobtchouk A; Cohen M; Fromell GJ; Laperrière L; Hill C; Langer A
    J Am Coll Cardiol; 2000 Nov; 36(5):1507-13. PubMed ID: 11079650
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of the platelet glycoprotein IIb/IIIa receptor with tirofiban in unstable angina and non-Q-wave myocardial infarction.
    Platelet Receptor Inhibition in Ischemic Syndrome Management in Patients Limited by Unstable Signs and Symptoms (PRISM-PLUS) Study Investigators
    N Engl J Med; 1998 May; 338(21):1488-97. PubMed ID: 9599103
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictors of recurrent ischemic events and death in unstable coronary artery disease after treatment with combination antithrombotic therapy.
    Cohen M; Stinnett SS; Weatherley BD; Gurfinkel EP; Fromell GJ; Goodman SG; Fox KA; Califf RM
    Am Heart J; 2000 Jun; 139(6):962-70. PubMed ID: 10827375
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aspirin, heparin, or both to treat acute unstable angina.
    Théroux P; Ouimet H; McCans J; Latour JG; Joly P; Lévy G; Pelletier E; Juneau M; Stasiak J; deGuise P
    N Engl J Med; 1988 Oct; 319(17):1105-11. PubMed ID: 3050522
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relation between systemic anticoagulation as determined by activated partial thromboplastin time and heparin measurements and in-hospital clinical events in unstable angina and non-Q wave myocardiaL infarction. Thrombolysis in Myocardial Ischemia III B Investigators.
    Becker RC; Cannon CP; Tracy RP; Thompson B; Bovill EG; Desvigne-Nickens P; Randall AM; Knatternud G; Braunwald E
    Am Heart J; 1996 Mar; 131(3):421-33. PubMed ID: 8604620
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low-molecular-weight heparins in non-ST-segment elevation ischemia: the ESSENCE trial. Efficacy and Safety of Subcutaneous Enoxaparin versus intravenous unfractionated heparin, in non-Q-wave Coronary Events.
    Cohen M; Demers C; Gurfinkel EP; Turpie AG; Fromell GJ; Goodman S; Langer A; Califf RM; Fox KA; Premmereur J; Bigonzi F
    Am J Cardiol; 1998 Sep; 82(5B):19L-24L. PubMed ID: 9737476
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Randomized trial of thrombolysis versus heparin in unstable angina.
    Schreiber TL; Rizik D; White C; Sharma GV; Cowley M; Macina G; Reddy PS; Kantounis L; Timmis GC; Margulis A
    Circulation; 1992 Nov; 86(5):1407-14. PubMed ID: 1423953
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Failure of adjuvant heparin to reduce myocardial ischemia in the early treatment of patients with unstable angina.
    Wallis DE; Boden WE; Califf R; Crawford MH; Hakki AH; Iskandrian AS; Labovitz A; O'Connor C; Sutton R; Scanlon PJ
    Am Heart J; 1991 Oct; 122(4 Pt 1):949-54. PubMed ID: 1681722
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Randomised comparison of subcutaneous heparin, intravenous heparin, and aspirin in unstable angina. Studio Epoorine Sottocutanea nell'Angina Instobile (SESAIR) Refrattorie Group.
    Neri Serneri GG; Modesti PA; Gensini GF; Branzi A; Melandri G; Poggesi L; Rostagno C; Tamburini C; Carnovali M; Magnani B
    Lancet; 1995 May; 345(8959):1201-4. PubMed ID: 7739307
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term oral anticoagulant therapy in patients with unstable angina or suspected non-Q-wave myocardial infarction: organization to assess strategies for ischemic syndromes (OASIS) pilot study results.
    Anand SS; Yusuf S; Pogue J; Weitz JI; Flather M
    Circulation; 1998 Sep; 98(11):1064-70. PubMed ID: 9736592
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of integrelin, a platelet glycoprotein IIb/IIIa receptor antagonist, in unstable angina. A randomized multicenter trial.
    Schulman SP; Goldschmidt-Clermont PJ; Topol EJ; Califf RM; Navetta FI; Willerson JT; Chandra NC; Guerci AD; Ferguson JJ; Harrington RA; Lincoff AM; Yakubov SJ; Bray PF; Bahr RD; Wolfe CL; Yock PG; Anderson HV; Nygaard TW; Mason SJ; Effron MB; Fatterpacker A; Raskin S; Smith J; Brashears L; Gottdiener P; du Mee C; Kitt MM; Gerstenblith G
    Circulation; 1996 Nov; 94(9):2083-9. PubMed ID: 8901655
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glycoprotein IIb/IIIa receptor blockade improves outcomes in diabetic patients presenting with unstable angina/non-ST-elevation myocardial infarction: results from the Platelet Receptor Inhibition in Ischemic Syndrome Management in Patients Limited by Unstable Signs and Symptoms (PRISM-PLUS) study.
    Théroux P; Alexander J; Pharand C; Barr E; Snapinn S; Ghannam AF; Sax FL
    Circulation; 2000 Nov; 102(20):2466-72. PubMed ID: 11076818
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prospective evaluation of a prostacyclin-sparing aspirin formulation and heparin/warfarin in aspirin users with unstable angina or non-Q wave myocardial infarction at rest. The Antithrombotic Therapy in Acute Coronary Syndromes Research Group.
    Cohen M; Parry G; Adams PC; Xiong J; Chamberlain D; Wieczorek I; Fox KA; Kronmal R; Fuster V
    Eur Heart J; 1994 Sep; 15(9):1196-203. PubMed ID: 7982419
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.